FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

However, that ruling had conflicted with a same-day injunction out of Texas, where Donald Trump-appointed U.S. District Judge Matthew Kacsmaryk ruled the FDA should not have approved the abortion drug ...

A federal appeals court has ruled that West Virginia can limit access to mifepristone, a medication used to end early ...

A recent appellate decision that allowed West Virginia to block access to the abortion-inducing drug mifepristone is fueling ...

Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...

Castle Biosciences' DecisionDx-Melanoma test and Revolution Medicines' elironrasib cancer drug receive FDA Breakthrough Designations. Read more here.

A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...

Pro-life advocates are rejoicing after a federal appeals court ruled this week that West Virginia is within its rights to ban ...

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.